ClinicalTrials.gg
Sign In

Drug

Vincristine Sulfate Liposome clinical trials

A product of Vincristine; its studies count on that page too.

studies test it
12
open now
0
in phase 3
3
first study started
2001

How studies write it

Studies that test it under each name

Name

Marqibo
8
Vincristine Sulfate Liposome
4
Vincristine sulfate liposome injection
2
Marqibo® (vincristine sulfate liposomes injection)
2

Combined with it in one product

Vincristine Sulfate Liposome Injection plus rituximab
1
Marqibo
1
VSLI
1
rituximab
1
rituxan
1

Studies by the year they started

12 studies that test it; most in 2007 (3)

Studies that test Vincristine Sulfate Liposome, by start year
YearStudies
20011
20051
20073
20101
20121
20131
20151
20172
20201

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
4
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it.

Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
2
Melanoma
2
Wilms Tumor
1
Neoplasms
1
Leukemia, Myeloid, Acute
1
Hematologic Diseases
1

Who runs them

Industry 8 · Other 4

Acrotech Biopharma Inc. (4) · Spectrum Pharmaceuticals, Inc (3) · Children's Oncology Group (1) · Therapeutic Advances in Childhood Leukemia Consortium (1) · Brown University (1) · Wake Forest University Health Sciences (1) · Nanjing Luye Sike Pharmaceutical Co., Ltd. (1)

Often tested with

Tested in the same studies.

Rituximab (2) · Cyclophosphamide (1) · Dactinomycin (1) · Doxorubicin (1) · Etoposide (1) · Bendamustine (1)

Studies

Open first, then newest update. How each study uses Vincristine Sulfate Liposome is read from its arms, and is right about nine times in ten.

Testing it · 12

Given in every arm · 7 — Vincristine Sulfate Liposome is usual care beside what is tested